HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Adult Data Tables

Print
PAGE 6 of 19

‹View Table of Contents

Related Pages

Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type, Adults, 2018-2021

Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type, Adults, 2018-2021
Acute Care Hospitals (n=3,550 hospitals)
Hospital ICUs Hospital Wards1 Hospital Oncology Units2 LTACHs3
(n=428 hospitals)		 IRFs or IRF Units4
(n=924 facilities)
Pathogen # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank
Escherichia coli 14,283 33.5 1 15,678 32.5 1 799 29.6 1 2,041 22.8 1 1,881 35.3 1
Select Klebsiella spp. 6,159 14.5 2 7,425 15.4 2 433 16.0 2 1,669 18.6 3 919 17.2 2
Pseudomonas aeruginosa 5,701 13.4 3 7,283 15.1 3 424 15.7 3 2,034 22.7 2 850 15.9 3
Enterococcus faecalis5 5,273 12.4 4 4,796 9.9 4 317 11.7 4 572 6.4 5 355 6.7 4
Proteus spp. 1,966 4.6 5 3,158 6.5 5 112 4.1 6 779 8.7 4 323 6.1 5
Enterobacter 1,930 4.5 6 2,042 4.2 6 122 4.5 5 397 4.4 7 252 4.7 6
Enterococcus faecium5 1,303 3.1 7 1,242 2.6 7 101 3.7 7 500 5.6 6 57 1.1 12
Coagulase-negative staphylococci 1,256 2.9 8 952 2.0 11 68 2.5 8 62 0.7 15 85 1.6 9
Other Enterococcus spp.5 980 2.3 9 989 2.0 10 48 1.8 11 87 1.0 13 77 1.4 10
Citrobacter spp. 780 1.8 10 1,025 2.1 8 64 2.4 9 147 1.6 8 138 2.6 7
Staphylococcus aureus 634 1.5 11 999 2.1 9 61 2.3 10 107 1.2 10 89 1.7 8
Serratia spp. 474 1.1 12 483 1.0 12 21 0.8 12 93 1.0 11 75 1.4 11
Morganella spp. 317 0.7 13 432 0.9 13 21 0.8 12 70 0.8 14 38 0.7 13
Acinetobacter spp. 156 0.4 14 234 0.5 14 13 0.5 14 120 1.3 9 27 0.5 14
Group B streptococci 131 0.3 15 108 0.2 16 9 0.3 16 3 <0.1 30 5 0.1 24
Other pathogen 1,273 3.0 1,467 3.0 90 3.3 290 3.2 160 3.0
Total 42,616 100.0 48,313 100.0 2,703 100.0 8,971 100.0 5,331 100.0

Note: Refer to Technical Resources for more information about the acronyms and terms used in this table.

Footnotes:

  1. Some rankings are not shown: Providencia stuartii (#15, 0.4%).
  2. Some rankings are not shown: Staphylococcus not specified (#15, 0.4%).
  3. Some rankings are not shown: Providencia stuartii (#12, 1.0%).
  4. Some rankings are not shown: Klebsiella variicola (#15, 0.3%).
  5. When analyzed at the genus-level, Enterococcus resulted in the following rankings: hospital ICUs (#2, 17.7%); hospital wards (#4, 14.5%); hospital oncology units (#2, 17.2%); LTACHs (#4, 12.9%); IRFs (#4, 9.2%).

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
  2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
  5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. ›Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
  7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
  8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
  10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
  12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
  13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  14. Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
  15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
  17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
  18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
  19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type